Equibles does not estimate personal net worth.
Get an email with a short summary when CapsoVision, Inc publishes a filing, an earnings call transcript or a press release.
Get CV alertsDavid Garcia is recorded as CFO at CapsoVision, Inc (CV) since November 3, 2025. CapsoVision, Inc reported in an 8-K filed November 3, 2025 that David Garcia was appointed principal financial officer and principal accounting officer, effective November 3, 2025. The proxy statement of CapsoVision, Inc reports total compensation of $625,282 for David Garcia in fiscal 2025, including a base salary of $50,000. David Garcia has spoken on 3 earnings calls and 1 other investor event across 1 company, most recently for CapsoVision, Inc on August 13, 2026. CapsoVision, Inc is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at CapsoVision, Inc includes David S. Shields (Board Member) and Dr. David S. Shields (Board Member).
“Effective as of November 3, 2025, David Garcia, Senior VP of Finance of CapsoVision, Inc. (the "Company"), has been appointed by the board of directors of the Company (the "Board") to serve as the Company's principal financial officer and principal accounting officer.”
“Turning to our commercial performance, we are pleased with the continued momentum in the business during the second quarter. As Johnny noted, more than 176,000 patients worldwide worldwide have now been imaged with CapsuCam Plus, compared with more than 143,000 at the end of Q2 2025.”
“Turning to our commercial performance, as of March 31, 1st, 2026, more than 167,000 patients have been imaged with CapsuCam Plus for small bowel screening across the U.S. and international markets.”
“Turning to our commercial performance, as Johnny highlighted earlier, adoption of Capsutam Plus continues to expand across both U.S. and international markets. As of December 31, 2025, more than 161,000 patients have been imaged using our system for small bowel screening.”
“And then you just announced preliminary results for the last quarter and did a $14 million dollar pipe maybe you can talk a little bit about kind of the burn rate cash position and run ray etc yeah uh thanks kyle um so as of december 31 we had 10.1 million of cash and equivalents and as you mentioned we just closed a…”
2025-11-03–present
Proxy statement
Start not stated–present
Last confirmed April 28, 2026
Medical Devices · Healthcare
CFO
2025-11-03–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | CapsoVision, Inc (CV) | Senior Vice President, Finance | $50,000 | $625,282 |
